This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

Managing Patients With Vascular Disease and Depression.

Steven P. Roose, MD; Alexander Glassman, MD; Sanjay J. Mathew, MD; J. Craig Nelson, MD; and David C. Steffens, MD

Published: October 16, 2006

Article Abstract

Click to enlarge page

Opening remarks by Steven P. Roose, M.D., set the tone for the serious topic of comorbid vascular disease and depression. In combination, these illnesses are deadly. Depression is a widely prevalent illness. The World Health Organization1 predicts that by the year 2020, depression will be the leading cause of morbidity worldwide.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 67

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...